MADISON, N.J., July 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing,
information and services, announced today that its second quarter results will
be made public on Tuesday, July 21, before the market opens. The company will
hold its quarterly conference call with investors to discuss the results
beginning at 8:30 a.m. Eastern Time on that day.
The public may access the conference call through a live audio webcast
available on Quest Diagnostics' Investor Relations Internet site at
www.QuestDiagnostics.com/investor.
The conference call can also be accessed in listen-only mode by dialing
415-228-4961, passcode 3214469. The company suggests participants dial in
approximately 10 minutes before the call.
A replay of the call may be accessed online at
www.QuestDiagnostics.com/investor or by phone at 866-395-9177 for domestic
callers, or 203-369-0501 for international callers. No access code will be
required. Telephone replays will be available from 10:30 a.m. Eastern Time on
July 21 until midnight Eastern Time on August 22, 2009.
Anyone listening to the Quest Diagnostics call is encouraged to read the
company's periodic reports, on file with the Securities and Exchange
Commission, including the discussion of risk factors and historical results of
operations and financial condition in those reports.
Quest Diagnostics is the world's leading provider of diagnostic testing,
information and services that patients and doctors need to make better
healthcare decisions. The company offers the broadest access to diagnostic
testing services through its national network of laboratories and patient
service centers, and provides interpretive consultation through its extensive
medical and scientific staff. Quest Diagnostics is a pioneer in developing
innovative new diagnostic tests and advanced healthcare information technology
solutions that help improve patient care. Additional company information is
available at: www.QuestDiagnostics.com.
Contacts:
Laure Park (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800
SOURCE Quest Diagnostics Incorporated